$ATRX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ATRIX LABORATORIES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ATRIX LABORATORIES INC. Get notifications about new insider transactions in ATRIX LABORATORIES INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chairman and CEO | Sell | S | 26.34 | 10,000 | 263,410 | 146,477 | 156.5 K to 146.5 K (-6.39 %) |
Apr 06 2004 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chairman and CEO | Buy | M | 6.88 | 10,000 | 68,800 | 156,477 | 146.5 K to 156.5 K (+6.83 %) |
Apr 05 2004 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr VP Clinical Rese ... | Option Exercise | A | 25.57 | 4,335 | 110,846 | 4,335 | |
Apr 05 2004 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr VP Clinical Rese ... | Option Exercise | A | 25.57 | 5,665 | 144,854 | 5,665 | |
Apr 02 2004 | ATRX | ATRIX LABORATORIES ... | GLICK MARGARET B | Corporate Controlle ... | Option Exercise | A | 25.50 | 8,236 | 210,018 | 8,236 | |
Apr 02 2004 | ATRX | ATRIX LABORATORIES ... | GLICK MARGARET B | Corporate Controlle ... | Option Exercise | A | 25.50 | 11,764 | 299,982 | 11,764 | |
Mar 22 2004 | ATRX | ATRIX LABORATORIES ... | VUTURO GEORGE J | Director | Buy | P | 24.53 | 10,000 | 245,300 | 26,336 | 16.3 K to 26.3 K (+61.21 %) |
Mar 22 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 1,400 | 12,600 | 2,100 | |
Mar 22 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 24.80 | 900 | 22,320 | 200 | 1.1 K to 200 (-81.82 %) |
Mar 22 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 25.00 | 500 | 12,500 | 1,100 | 1.6 K to 1.1 K (-31.25 %) |
Mar 22 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | M | 9.00 | 1,400 | 12,600 | 1,600 | 200 to 1.6 K (+700.00 %) |
Mar 17 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 3,500 | |
Mar 17 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 25.23 | 500 | 12,615 | 200 | 700 to 200 (-71.43 %) |
Mar 17 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | M | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Mar 02 2004 | ATRX | ATRIX LABORATORIES ... | VIETOR RICHARD R | Director | Grant | A | 27.05 | 97 | 2,624 | 336 | 239 to 336 (+40.59 %) |
Mar 17 2004 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr VP Clinical Rese ... | Sell | S | 24.26 | 1,500 | 36,390 | 12,900 | 14.4 K to 12.9 K (-10.42 %) |
Mar 02 2004 | ATRX | ATRIX LABORATORIES ... | BAZAN NICHOLAS G | Director | Grant | A | 27.05 | 79 | 2,137 | 3,040 | 3 K to 3 K (+2.67 %) |
Mar 02 2004 | ATRX | ATRIX LABORATORIES ... | VUTURO GEORGE J | Director | Grant | A | 27.05 | 109 | 2,948 | 16,336 | 16.2 K to 16.3 K (+0.67 %) |
Mar 02 2004 | ATRX | ATRIX LABORATORIES ... | VUTURO GEORGE J | Director | Grant | A | 27.05 | 109 | 2,948 | 16,336 | 16.2 K to 16.3 K (+0.67 %) |
Mar 02 2004 | ATRX | ATRIX LABORATORIES ... | CAMPBELL H STUART | Director | Grant | A | 27.05 | 160 | 4,328 | 35,393 | 35.2 K to 35.4 K (+0.45 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,000 | |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 26.90 | 500 | 13,450 | 200 | 700 to 200 (-71.43 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Grant | A | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,000 | |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 26.90 | 500 | 13,450 | 200 | 700 to 200 (-71.43 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Grant | A | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,000 | |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 26.90 | 500 | 13,450 | 200 | 700 to 200 (-71.43 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Grant | A | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,000 | |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 26.90 | 500 | 13,450 | 200 | 700 to 200 (-71.43 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Grant | A | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,000 | |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 26.90 | 500 | 13,450 | 200 | 700 to 200 (-71.43 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Grant | A | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,000 | |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 26.90 | 500 | 13,450 | 200 | 700 to 200 (-71.43 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Grant | A | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Feb 19 2004 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr VP Clinical Rese ... | Sell | S | 26.90 | 2,000 | 53,800 | 14,400 | 16.4 K to 14.4 K (-12.20 %) |
Feb 05 2004 | ATRX | ATRIX LABORATORIES ... | GOULD GREGORY A | Chief Financial Off ... | Option Exercise | A | 24.96 | 12,019 | 299,994 | 12,019 | |
Feb 05 2004 | ATRX | ATRIX LABORATORIES ... | GOULD GREGORY A | Chief Financial Off ... | Option Exercise | A | 24.96 | 32,981 | 823,206 | 32,981 | |
Jan 07 2004 | ATRX | ATRIX LABORATORIES ... | STRYCKER MICHAEL | Corporate Controlle ... | Option Exercise | A | 25.16 | 11,900 | 299,404 | 11,900 | |
Jan 07 2004 | ATRX | ATRIX LABORATORIES ... | STRYCKER MICHAEL | Corporate Controlle ... | Option Exercise | A | 25.16 | 8,100 | 203,796 | 8,100 | |
Jan 20 2004 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Senior VP Clinical ... | Sell | S | 25.05 | 2,000 | 50,100 | 16,400 | 18.4 K to 16.4 K (-10.87 %) |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,500 | |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | S | 24.80 | 500 | 12,400 | 200 | -300 to 200 (-166.67 %) |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | M | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,500 | |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | S | 24.80 | 500 | 12,400 | 200 | -300 to 200 (-166.67 %) |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | M | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Jan 20 2004 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Senior VP Clinical ... | Sell | S | 25.05 | 2,000 | 50,100 | 16,400 | 18.4 K to 16.4 K (-10.87 %) |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 4,500 | |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | S | 24.80 | 500 | 12,400 | 200 | -300 to 200 (-166.67 %) |
Jan 16 2004 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | M | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Dec 22 2003 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr VP Clinical Rese ... | Gift | G | 22.32 | 1,500 | 33,480 | 18,400 | 19.9 K to 18.4 K (-7.54 %) |
Dec 17 2003 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | M | 9.00 | 500 | 4,500 | 5,000 | |
Dec 17 2003 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Sell | S | 22.85 | 500 | 11,425 | 200 | 700 to 200 (-71.43 %) |
Dec 17 2003 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Buy | M | 9.00 | 500 | 4,500 | 700 | 200 to 700 (+250.00 %) |
Dec 17 2003 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr VP Clinical Rese ... | Sell | S | 22.15 | 1,000 | 22,150 | 19,900 | 20.9 K to 19.9 K (-4.78 %) |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | VIETOR RICHARD R | Director | Grant | A | 22.32 | 159 | 3,549 | 239 | 80 to 239 (+198.75 %) |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | YARBOROUGH CODY L | VP Dermatology Divi ... | Option Exercise | A | 22.32 | 5,000 | 111,600 | 5,000 | |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Sr. VP Clinical Res ... | Option Exercise | A | 22.32 | 10,000 | 223,200 | 10,000 | |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | VUTURO GEORGE J | Director | Grant | A | 22.32 | 79 | 1,763 | 16,227 | 16.1 K to 16.2 K (+0.49 %) |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | BAZAN NICHOLAS G | Director | Grant | A | 22.32 | 79 | 1,763 | 2,950 | 2.9 K to 3 K (+2.75 %) |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | WARREN STEPHEN L | VP Research and Dev ... | Option Exercise | A | 22.32 | 15,000 | 334,800 | 15,000 | |
Dec 10 2003 | ATRX | ATRIX LABORATORIES ... | DUNCAN MICHAEL R | VP & General Manage ... | Option Exercise | A | 22.32 | 12,000 | 267,840 | 12,000 | |
Dec 04 2003 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Option Exercise | M | 9.72 | 26,000 | 252,694 | 14,000 | |
Dec 04 2003 | ATRX | ATRIX LABORATORIES ... | BETHUNE DAVID R | Chief Executive Off ... | Buy | M | 9.72 | 26,000 | 252,694 | 146,477 | 120.5 K to 146.5 K (+21.58 %) |
Sep 29 2003 | ATRX | ATRIX LABORATORIES ... | VIETOR RICHARD R | Director | Grant | A | 21.85 | 80 | 1,748 | 80 | 0 to 80 |
Sep 29 2003 | ATRX | ATRIX LABORATORIES ... | VIETOR RICHARD R | Director | Grant | A | 21.85 | 80 | 1,748 | 80 | 0 to 80 |
Sep 29 2003 | ATRX | ATRIX LABORATORIES ... | FLAUM SANDER A | Director | Grant | A | 21.85 | 80 | 1,748 | 4,174 | 4.1 K to 4.2 K (+1.95 %) |
Sep 29 2003 | ATRX | ATRIX LABORATORIES ... | VUTURO GEORGE J | Director | Grant | A | 21.85 | 80 | 1,748 | 16,148 | 16.1 K to 16.1 K (+0.50 %) |
Sep 29 2003 | ATRX | ATRIX LABORATORIES ... | BAZAN NICHOLAS G | Director | Grant | A | 21.85 | 80 | 1,748 | 2,871 | 2.8 K to 2.9 K (+2.87 %) |
Sep 26 2003 | ATRX | ATRIX LABORATORIES ... | VIETOR RICHARD R | Director | Option Exercise | A | 22.74 | 25,000 | 568,500 | 25,000 | |
Aug 21 2003 | ATRX | ATRIX LABORATORIES ... | GARRETT J STEVEN | Senior VP, Clinical ... | Gift | G | 27.75 | 1,000 | 27,750 | 4,420 | 5.4 K to 4.4 K (-18.45 %) |
Aug 25 2003 | ATRX | ATRIX LABORATORIES ... | COHEN D WALTER | Director | Option Exercise | M | 9.63 | 10,000 | 96,250 | 0 | |
Aug 25 2003 | ATRX | ATRIX LABORATORIES ... | COHEN D WALTER | Director | Payment of Exercise | F | 29.27 | 3,288 | 96,240 | 15,583 | 18.9 K to 15.6 K (-17.42 %) |
Aug 25 2003 | ATRX | ATRIX LABORATORIES ... | COHEN D WALTER | Director | Buy | M | 9.63 | 10,000 | 96,250 | 18,871 | 8.9 K to 18.9 K (+112.73 %) |
Aug 19 2003 | ATRX | ATRIX LABORATORIES ... | VUTURO GEORGE J | Director | Grant | A | 25.35 | 69 | 1,749 | 16,068 | 16 K to 16.1 K (+0.43 %) |
Aug 15 2003 | ATRX | ATRIX LABORATORIES ... | BAZAN NICHOLAS G | Director | Gift | G | 10.06 | 5,000 | 50,313 | 2,722 | 7.7 K to 2.7 K (-64.75 %) |
Aug 13 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | Vice President - De ... | Option Exercise | M | 9.72 | 6,000 | 58,314 | 6,000 | |
Aug 13 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | Vice President - De ... | Sell | S | 24.31 | 6,000 | 145,860 | 5,647 | 11.6 K to 5.6 K (-51.52 %) |
Aug 13 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | Vice President - De ... | Buy | M | 9.72 | 6,000 | 58,314 | 11,647 | 5.6 K to 11.6 K (+106.25 %) |
Aug 19 2003 | ATRX | ATRIX LABORATORIES ... | BAZAN NICHOLAS G | Director | Grant | A | 25.35 | 69 | 1,749 | 2,791 | 2.7 K to 2.8 K (+2.53 %) |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Option Exercise | M | 9.72 | 5,000 | 48,595 | 5,000 | |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Option Exercise | M | 9.50 | 10,000 | 95,000 | 10,000 | |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Option Exercise | M | 9.75 | 5,000 | 48,750 | 5,000 | |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Sell | S | 24.05 | 5,000 | 120,250 | 5,647 | 10.6 K to 5.6 K (-46.96 %) |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Buy | M | 9.72 | 5,000 | 48,595 | 10,647 | 5.6 K to 10.6 K (+88.54 %) |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Sell | S | 23.93 | 10,000 | 239,300 | 5,647 | 15.6 K to 5.6 K (-63.91 %) |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Buy | M | 9.50 | 10,000 | 95,000 | 15,647 | 5.6 K to 15.6 K (+177.09 %) |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Sell | S | 23.76 | 5,000 | 118,800 | 5,647 | 10.6 K to 5.6 K (-46.96 %) |
Aug 08 2003 | ATRX | ATRIX LABORATORIES ... | OSBORNE DAVID W | VP Dermatology | Buy | M | 9.75 | 5,000 | 48,750 | 10,647 | 5.6 K to 10.6 K (+88.54 %) |
Aug 15 2003 | ATRX | ATRIX LABORATORIES ... | WALLACE MARK A | Chief Financial Off ... | Option Exercise | A | 24.01 | 50,000 | 1,200,500 | 0 |